Thermo Fisher Scientific, Eli Lilly and Company, and D-Wave Quantum are the three Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies whose primary business is researching, developing, manufacturing and marketing medicinal drugs and therapies. Investors in these stocks typically look for growth driven by successful drug approvals, patent protection and global healthcare demand, while also weighing risks such as regulatory setbacks, patent expirations and competitive pressures. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.
Thermo Fisher Scientific (TMO)
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Shares of Thermo Fisher Scientific stock traded up $43.74 during trading on Wednesday, hitting $471.36. 6,401,875 shares of the company were exchanged, compared to its average volume of 2,054,126. The firm's fifty day moving average price is $410.38 and its 200 day moving average price is $472.32. The firm has a market capitalization of $177.93 billion, a P/E ratio of 27.69, a price-to-earnings-growth ratio of 1.96 and a beta of 0.77. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.77 and a quick ratio of 1.38. Thermo Fisher Scientific has a 1-year low of $385.46 and a 1-year high of $627.88.
Read Our Latest Research Report on TMO
Eli Lilly and Company (LLY)
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.
Shares of LLY stock traded up $20.85 during trading on Wednesday, reaching $797.29. The company's stock had a trading volume of 1,633,960 shares, compared to its average volume of 3,652,618. The business has a fifty day moving average price of $767.03 and a 200-day moving average price of $800.17. Eli Lilly and Company has a one year low of $677.09 and a one year high of $972.53. The company has a quick ratio of 1.06, a current ratio of 1.37 and a debt-to-equity ratio of 2.18. The company has a market cap of $755.62 billion, a price-to-earnings ratio of 64.91, a price-to-earnings-growth ratio of 1.10 and a beta of 0.40.
Read Our Latest Research Report on LLY
D-Wave Quantum (QBTS)
D-Wave Quantum Inc. develops and delivers quantum computing systems, software, and services worldwide. The company offers Advantage, a fifth-generation quantum computer; Ocean, a suite of open-source python tools; and Leap, a cloud-based service that provides real-time access to a live quantum computer, as well as access to Advantage, hybrid solvers, the Ocean software development kit, live code, demos, learning resources, and a vibrant developer community.
NYSE QBTS traded up $1.78 during trading on Wednesday, reaching $19.37. 51,379,460 shares of the company's stock were exchanged, compared to its average volume of 49,997,536. D-Wave Quantum has a fifty-two week low of $0.75 and a fifty-two week high of $20.56. The stock has a market capitalization of $5.66 billion, a P/E ratio of -32.31 and a beta of 1.40. The business has a 50 day moving average price of $15.84 and a 200-day moving average price of $9.97. The company has a debt-to-equity ratio of 0.15, a current ratio of 20.73 and a quick ratio of 20.61.
Read Our Latest Research Report on QBTS
Recommended Stories
Before you consider Thermo Fisher Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Thermo Fisher Scientific wasn't on the list.
While Thermo Fisher Scientific currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
